Fact CheckerSign in

NCT06973590Recruiting

Blood Flow Restriction and Transcutaneous Electrical Nerve Stimulation on Motor Function in Stroke

Effects of Low-intensity Resistance Training With Blood Flow Restriction and Transcutaneous Electrical Nerve Stimulation on Lower Limb Motor Function in People With Stroke

Source: ClinicalTrials.gov · Last updated 21 Aug 2026

Brief summary (registry, in English)

Stroke commonly results in persistent leg impairments that limit mobility and reduce quality of life. This study investigates whether combining low-intensity resistance training with blood flow restriction (LIRT-BFR) and transcutaneous electrical nerve stimulation (TENS) can effectively improve leg function in stroke survivors. Participants with chronic stroke will be randomly assigned to one of four intervention groups: 1) LIRT with simulated BFR and simulated TENS; 2) LIRT with actual BFR and simulated TENS; 3) LIRT with simulated BFR and actual TENS; 4) LIRT with both actual BFR and actual TENS. The resistance training utilizes 20% of each participant's maximum lifting capacity. For blood flow restriction, an automated pressure cuff (SmartCuffs 4.0) will be placed on the upper portion of the affected leg, inflated to 50% of the individual's occlusion pressure during exercises and deflated during rest periods. TENS therapy delivers controlled electrical impulses through electrodes positioned on the anterior thigh. Each 60-minute session includes a 10-minute warm-up followed by 40 minutes of targeted resistance exercises (leg extensions, leg presses, and weight-bearing squats) and concludes with 10 minutes of stationary cycling. The resistance protocol involves 3 sets of 20 repetitions with standardized rest intervals between sets and exercises. Participants will attend three sessions weekly for six weeks. Assessments will be conducted at baseline, midpoint (3 weeks), completion (6 weeks), and follow-up (1 month post-intervention). The primary outcome measure is the Fugl-Meyer Assessment for Lower Extremity function, with secondary measures including muscle strength, stiffness, balance, mobility, walking capacity, and gait parameters. To understand the underlying mechanisms, we will measure muscle oxygenation using near-infrared spectroscopy, evaluate muscle structure via ultrasound, and monitor physiological responses including heart rate variability and perceived exertion for safety monitoring.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
7 May 2025
Start date
Sept 2024
Primary completion date
Dec 2026
Lead sponsor
The Hong Kong Polytechnic University
Diseases
Stroke
NCT number
NCT06973590

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From Sept 2024 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • administration of botulinum toxin in the lower limb at least 6 months prior to training;

Other illness

  • presence of other comorbidities like varicose veins, peripheral neuropathy, cancer, musculoskeletal injury, lower limb peripheral edema, post-surgical swelling, open wounds, or on a medication that increases blood clotting risk;
  • resting blood pressure ≥ 160/100 mmHg even after taking medications, cardiovascular comorbidity, heart failure, unstable angina, by-pass surgery, a pacemaker;
  • history of epilepsy, cochlear implants, any type of deep brain stimulator and metal implants in the head or neck;

Other

  • currently not participating in resistance training or high-intensity or long duration cardiovascular exercise;
  • lack the ability to feel pain (because of paralysis), or other subjects who cannot complain of discomfort.

Who the study is looking for

  • are between 50 and 80 years of age;
  • have had a single stroke more than 6 months and less than 15 years;
  • have at least 5 degrees of active ankle dorsiflexion in the antigravity position;
  • are able to walk 10 m independently, with or without a walking aid;
  • are able to score 6 or higher out of 10 on the abbreviated mental test;
  • have no skin allergies (e.g. redness or itchiness after application of the electrical stimulation pads) to electrical stimulation or electrodes;
  • are able to follow instructions and give informed consent.

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Hong Kong Polytechnic University
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.